← Evidence map

ArticleeNeurologicalSci2025

Corrigendum to "Oral minocycline therapy as first-line treatment in patients with Myalgic encephalomyelitis and long COVID: A pilot study" [eNeurologicalSci 38 (2025) 100537].

Kunihisa MiwaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Corrigendum to "Oral minocycline therapy as first-line treatment in patients with Myalgic encephalomyelitis and long COVID: A pilot study" [eNeurologicalSci 38 (2025) 100537]. | OpenQuestion